Your browser doesn't support javascript.
loading
Omadacycline Pharmacokinetics/Pharmacodynamics in the Hollow Fiber System Model and Potential Combination Regimen for Short Course Treatment of Mycobacterium kansasii Pulmonary Disease.
Singh, Sanjay; Gumbo, Tawanda; Boorgula, Gunavanthi D; Shankar, Prem; Heysell, Scott K; Srivastava, Shashikant.
Affiliation
  • Singh S; Department of Pulmonary Immunology, University of Texas Health Science Centre at Tyler, Tyler, Texas, USA.
  • Gumbo T; Quantitative Preclinical & Clinical Sciences Department, Praedicare Inc., Dallas, Texas, USA.
  • Boorgula GD; Hollow Fiber System & Experimental Therapeutics Laboratories, Praedicare Inc., Dallas, Texas, USA.
  • Shankar P; Department of Pulmonary Immunology, University of Texas Health Science Centre at Tyler, Tyler, Texas, USA.
  • Heysell SK; Department of Pulmonary Immunology, University of Texas Health Science Centre at Tyler, Tyler, Texas, USA.
  • Srivastava S; Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA.
Antimicrob Agents Chemother ; 66(9): e0068722, 2022 09 20.
Article in En | MEDLINE | ID: mdl-35976006
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia / Plantas_medicinales Main subject: Mycobacterium kansasii / Lung Diseases Type of study: Prognostic_studies Language: En Journal: Antimicrob Agents Chemother Year: 2022 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia / Plantas_medicinales Main subject: Mycobacterium kansasii / Lung Diseases Type of study: Prognostic_studies Language: En Journal: Antimicrob Agents Chemother Year: 2022 Type: Article Affiliation country: United States